Electrophysiological characteristics of patients with nitrous oxide abuse

References

• Kaar SJ, Ferris J, Waldron J, et al. Up: the rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use. J Psychopharmacol (Oxford, England). 2016;30:395–401.
   PubMed Web of Science ®Google Scholar
• van Amsterdam J, Nabben T. Recreational nitrous oxide use: prevalence and risks. Regul Toxicol Pharmacol. 2015;73:790–796.
   PubMed Web of Science ®Google Scholar
• Sahenk Z, Mendell JR, Couri D, et al. Polyneuropathy from inhalation of N2O cartridges through a whipped-cream dispenser. Neurology. 1978;28:485–487.
   PubMed Web of Science ®Google Scholar
• Bao L, Li Q, Li Q, et al. Clinical, electrophysiological and radiological features of nitrous oxide-induced neurological disorders. Neuropsychiatr Dis Treat. 2020;16:977–984.
   PubMed Web of Science ®Google Scholar
• Garakani A, Jaffe RJ, Savla D, et al. Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: a systematic review of the case literature. Am J Addict. 2016;25:358–369.
   PubMed Web of Science ®Google Scholar
• Dubrey S, Smith R. ‘Whippits’: nitrous oxide gas inhalation as recreational drug use. Br J Hosp Med (London, England : 2005). 2016;77:492.
   Web of Science ®Google Scholar
• Chiang TT, Hung CT, Wang WM, et al. Recreational nitrous oxide abuse-induced vitamin B12 deficiency in a patient presenting with hyperpigmentation of the skin. Case Rep Dermatol. 2013;5:186–191.
   PubMedGoogle Scholar
• Lin RJ, Chen HF, Chang YC, et al. Subacute combined degeneration caused by nitrous oxide intoxication: case reports. Acta Neurol Taiwan. 2011;20:129–137.
   PubMedGoogle Scholar
• Alt RS, Morrissey RP, Gang MA, et al. Severe myeloneuropathy from acute high-dose nitrous oxide (N2O) abuse. J Emerg Med. 2011;41:378–380.
   PubMed Web of Science ®Google Scholar
• Cheng HM, Park JH, Hernstadt D. Subacute combined degeneration of the spinal cord following recreational nitrous oxide use. BMJ Case Reports. 2013;2013.
   Google Scholar
• Winstock AR, Ferris JA. Nitrous oxide causes peripheral neuropathy in a dose dependent manner among recreational users. J Psychopharmacol. 2020;34:229–236.
   PubMed Web of Science ®Google Scholar
• Zheng D, Ba F, Bi G, et al. The sharp rise of neurological disorders associated with recreational nitrous oxide use in China: a single-center experience and a brief review of Chinese literature. J Neurol. 2020;267:422–429.
   PubMed Web of Science ®Google Scholar
• Dong X, Ba F, Wang R, et al. Imaging appearance of myelopathy secondary to nitrous oxide abuse: a case report and review of the literature. The International journal of neuroscience 2018:1–10.
   Google Scholar
• Hiew FL, Ramlan R, Viswanathan S, et al. Guillain-Barre Syndrome, variants & forms fruste: reclassification with new criteria. Clin Neurol Neurosurg. 2017;158:114–118.
   PubMed Web of Science ®Google Scholar
• Uncini A, Ippoliti L, Shahrizaila N, et al. Optimizing the electrodiagnostic accuracy in Guillain-Barré syndrome subtypes: criteria sets and sparse linear discriminant analysis. Clin Neurophysiol. 2017;128:1176–1183.
   PubMed Web of Science ®Google Scholar
• Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update. Clin Neurophysiol. 2012;123:1487–1495.
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285–2293.
   PubMed Web of Science ®Google Scholar
• Zheng R, Wang Q, Li M, et al. Reversible neuropsychiatric disturbances caused by nitrous oxide toxicity: clinical, imaging and electrophysiological profiles of 21 patients with 6-12 months follow-up. Neuropsychiatr Dis Treat. 2020;16:2817–2825.
   PubMed Web of Science ®Google Scholar
• van Doorn PA. Diagnosis, treatment and prognosis of Guillain-Barre syndrome (GBS). Presse Med (Paris, France : 1983). 2013;42:e193–201.
   PubMedGoogle Scholar
• Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma exchange/sandoglobulin Guillain-Barre syndrome trial group. Ann Neurol. 1998;44:780–788.
   PubMed Web of Science ®Google Scholar
• Wang TY, Chen SC, Peng CW, et al. Relevance of nerve conduction velocity in the assessment of balance performance in older adults with diabetes mellitus. Disabil Rehabil. 2017;39:419–427.
   PubMed Web of Science ®Google Scholar
• JTFotEat PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopgy in the dagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Journal of the Peripheral Nervous System 2010;15:79–92.
   Google Scholar
• Randhawa G, Bodenham A. The increasing recreational use of nitrous oxide: history revisited. Br J Anaesth. 2016;116:321–324.
   PubMed Web of Science ®Google Scholar
• Hew A, Lai E, Radford E. Nitrous oxide abuse presenting with acute psychosis and peripheral neuropathy. Aust N Z J Psychiatry. 2018;52:388.
   PubMed Web of Science ®Google Scholar
• Thompson AG, Leite MI, Lunn MP, et al. Whippits, nitrous oxide and the dangers of legal highs. Pract Neurol. 2015;15:207–209.
   PubMedGoogle Scholar
• Richardson PG. Peripheral neuropathy following nitrous oxide abuse. Emerg Med Australas. 2010;22:88–90.
   PubMed Web of Science ®Google Scholar
• Savage S, Ma D. The neurotoxicity of nitrous oxide: the facts and “putative” mechanisms. Brain Sci. 2014;4:73–90.
   PubMedGoogle Scholar
• Kumar N. Neurologic aspects of cobalamin (B12) deficiency. Handb Clin Neurol. 2014;120:915–926.
   PubMedGoogle Scholar
• Patel KK, Mejia Munne JC, Gunness VRN, et al. Subacute combined degeneration of the spinal cord following nitrous oxide anesthesia: a systematic review of cases. Clin Neurol Neurosurg. 2018;173:163–168.
   PubMed Web of Science ®Google Scholar
• Franques J, Chiche L, De Paula AM, et al. Characteristics of patients with vitamin B12-responsive neuropathy: a case series with systematic repeated electrophysiological assessment. Neurol Res. 2019;41:569–576.
   PubMed Web of Science ®Google Scholar
• Tani J, Weng HY, Chen HJ, et al. Elucidating unique axonal dysfunction between nitrous oxide abuse and Vitamin B12 deficiency. Front Neurol. 2019;10:704.
   PubMed Web of Science ®Google Scholar
• Staff NP, Windebank AJ. Peripheral neuropathy due to vitamin deficiency, toxins, and medications. Continuum (Minneap Minn). 2014;20:1293–1306.
   PubMedGoogle Scholar
• Koike H, Takahashi M, Ohyama K, et al. Clinicopathologic features of folate-deficiency neuropathy. Neurology. 2015;84:1026–1033.
   PubMed Web of Science ®Google Scholar
• Wakerley BR, Uncini A, Yuki N. Guillain-Barré and Miller Fisher syndromes--new diagnostic classification. Nat Rev Neurol. 2014;10:537–544.
   PubMed Web of Science ®Google Scholar
• Kuwabara S, Yuki N. Axonal Guillain-Barre syndrome: concepts and controversies. Lancet Neurol. 2013;12:1180–1188.
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012;28(Suppl 1):8–14.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Zochodne DW. Diabetic neuropathy and the sensory neuron: new aspects of pathogenesis and their treatment implications. J Diabetes Investig. 2018;9:1239–1254.
   PubMed Web of Science ®Google Scholar